GRN and mild neurocognitive disorder: Clinical manifestations, age of onset, duration of illness and distribution of neuropathological changes of PGRN gene mutation carriers are variable: the majority have progressive aphasia or frontotemporal dementia, but without symptoms of MND or PSP [13,15].